Instapath Inc.

Instapath Inc. manufactures rapid tissue imaging systems that digitize pathology specimens without destructive processing. The company offers a portfolio of fluorescence microscopy platforms designed for point-of-procedure tissue analysis, fresh-specimen imaging, and remote scanning services. Neo is a Class I medical device employing patented fluorescence microscopy to determine tissue composition immediately during procedures without sample alteration. Luci enables large-specimen imaging of fresh, fixed, or frozen samples without laborious histological processing or tissue loss, preserving samples for downstream molecular and analytical testing. LuciNow is a complementary remote slide-scanning service offering on-demand specimen analysis through a service-based model. The technology addresses pathology workflows in surgical, research, and diagnostic settings where rapid, non-destructive tissue characterization is critical. Instapath's systems are designed for hospitals, research institutions, and clinical laboratories requiring immediate tissue assessment without compromising sample integrity for subsequent testing. The company targets physicians, researchers, and healthcare organizations seeking to reduce turnaround time and eliminate tissue waste in pathology workflows.